why choose us

First received: September 01, 2023

Clinical Trial: Anticoagulant-associated Intracranial Hemorrhage

Study Status: Completed

Recruit Status: RECRUITING

Condition: Anticoagulant-induced Bleeding

Study Type: OBSERVATIONAL


Official Title: Anticoagulant-associated Intracranial Hemorrhage: Patient Characteristics and Outcomes From National Institute of Neurology and Neurosurgery Manuel Velasco: Single-Center Observational Study

Brief Summary: Oral anticoagulant therapy, including factors Xa and 2a inhibitors has become more popular in recent years due to its efficacy and convenience in preventing thrombotic events and reducing the risk for stroke in patients with rosk factors (e.g.atrial fibrillation, deep venous thrombosis, pulmonary embolism).These drugs have replaced traditional therapies such as warfarin, which requires frequent dose adjustments and control blood samples.Warfarin also has a higher risk of bleeding events.Many patients with atrial…

Read more